<code id='7B29B3362E'></code><style id='7B29B3362E'></style>

<acronym id='7B29B3362E'></acronym>

<center id='7B29B3362E'><center id='7B29B3362E'><tfoot id='7B29B3362E'></tfoot></center><abbr id='7B29B3362E'><dir id='7B29B3362E'><tfoot id='7B29B3362E'></tfoot><noframes id='7B29B3362E'>

<optgroup id='7B29B3362E'><strike id='7B29B3362E'><sup id='7B29B3362E'></sup></strike><code id='7B29B3362E'></code></optgroup>

<b id='7B29B3362E'><label id='7B29B3362E'><select id='7B29B3362E'><dt id='7B29B3362E'><span id='7B29B3362E'></span></dt></select></label></b><u id='7B29B3362E'></u>

~~<i id='7B29B3362E'><strike id='7B29B3362E'><tt id='7B29B3362E'><pre id='7B29B3362E'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

leisure time

author：explore 2025-09-29 12:22:10 Page View：8

Alexis Borisy — Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare drug price negotiation hasn't dried up venture capital
Next article： Drug repurposing or repositioning? The language matters

explore

Moonlake's readout produced a cash windfall. Risks remain

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

Keeping primary care docs in field isn't impossible, says AAFP CEO

Keeping primary care docs in field isn't impossible, says AAFP CEO

R.ShawnMartin,theCEOoftheAmericanAcademyofFamilyPhysiciansCourtesyAmericanAcademyofFamilyPhysiciansI

State Dept. review finds Biden bears some blame for Afghanistan failures

State Dept. review finds Biden bears some blame for Afghanistan failures

3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

Life sciences deals on track to hit lowest point since 2017

AdobeIt’snosecretthatbiotechindustryfundinghasfallenfromitsCovidhighs.Butwithjustafewmonthsleftinthe

read more